Summary
Cyclosporin blood trough levels were measured with four different immunoassays and high-performance liquid chromatography in 12 patients receiving low-dose steroids and CsA after kidney transplantation. These patients represent a selection with an uncomplicated posttransplant course and received no drugs with a known influence on CsA pharmacokinetics. The use of specific antibodies against the parent drug yielded levels comparable to those detected by HPLC. CsA levels measured with nonspecific antibodies exceeded those measured with specific ones by a factor of two to three. All immunoassay-detected CsA levels correlated significantly with the HPLC-determined CsA levels. In addition, blood levels of the CsA metabolites 1, 17, 18, and 21 were determined by HPLC. In one additional patient, who was under tuberculostatic treatment and had a transitory deterioration of liver function, levels of nonspecificantibody-determined CsA rose, as confirmed by rising levels of metabolite 17, while those of the parent drug fell. We conclude that routine drug monitoring should include at least one immunoassay with a specific antibody detecting the unchanged CsA, and a supplementary immunoassay with a nonspecific antibody detecting a composition of cross-reacting metabolites plus the unchanged substance. If available, HPLC should be used to confirm levels of CsA and its metabolites in patients with suspected alteration of their CsA metabolism.
Similar content being viewed by others
Abbreviations
- CsA:
-
cyclosporin
- RIA:
-
radioimmunoassay
- HPLC:
-
high-performance liquid chromatography
- nAB:
-
nonspecific antibody
- sAB:
-
specific antibody
References
Abbot laboratories, product information (1987) TDX-systems. Abbot Diagnostic Products, Wiesbaden, Germany
Ball PE, Munzer H, Keller HP, Abisch E, Rosenthaler J (1988) Specific3H radioimmunoassay with a monoclonal antibody for monitoring cyclosporine in blood. Clin Chem 34:257–260
Christians U, Zimmer K-O, Wonigeit K, Sewing K-Fr (1987) Measurement of cyclosporin A and of four metabolites in whole blood by high-performance liquid chromatography. J Chromatogr 413:121–129
Donatsch P, Abisch E, Homberger M, Traber R, Trapp M, Voger R (1981) A radioimmunoassay to measure cyclosporin A in plasma and serum samples. J Immunoassay 2:19–32
Freed BM, Rosano TG, Lempert N (1987) In vitro immunosuppressive properties of cyclosporine metabolites. Transplantation 43:123–127
Langhoff E, Madsen S (1983) Rapid metabolism of cyclosporine and prednisone in kidney transplant patients on tuberculostatic treatment. Lancet II:1303
Lensmeyer GL, Wiebe DA (1988) An evaluation of the Abbott TDX FPIA for cyclosporine and metabolites in whole blood: cross reactivity of metabolites. University of Wisconsin, Toxicology Research Laboratory
Leunissen K, Bosman F, Beuman G, van Hoof J (1987) Cyclosporine metabolites and nephrotoxicity. Second International Congress on Cyclosporine, Washington DC, Nov. 4–7 1987, book of abstracts, p 239
Maurer G, Lemaire M (1986) Biotransformation and distribution in blood of cyclosporine and its metabolites. Transplant Proc [Suppl 5] 18:25–34
Ryffel B, Hiestand P, Foxwell P, Donatsch P, Boelsterli H-J, Maurer G, Mihatsch M-J (1986) Nephrotoxic and immunosuppressive potentials of cyclosporine metabolites in rats. Transplant Proc [Suppl 5] 6:41–45
Sandoz Ltd., product information (1987) Sandimmune-kit. Sandoz, Basel, Switzerland
Wadhwa NK, Schroeder TJ, Pesce AJ, Myre SA, Clardy CW, First MR (1987) Cyclosporine drug interactions: a review. Ther Drug Monit 9:399–406
Wonigeit K (1988) Gegenwärtiger Stand der Immunsuppression bei der Organtransplantation. Chirurg 59:447–453
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kunzendorf, U., Brockmöller, J., Jochimsen, F. et al. Cyclosporin drug monitoring: Comparison of four immunoassays and HPLC. Klin Wochenschr 67, 438–441 (1989). https://doi.org/10.1007/BF01725139
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01725139